Sodium arsenite impairs insulin secretion and transcription in pancreatic β-cells

Toxicology and Applied Pharmacology

Volumn 214, Issue 1, 2006, Pages 30-34

  Díaz Villaseñor, Andrea ^a   Sánchez Soto, M Carmen ^b   Cebrián, Mariano E ^c   Ostrosky Wegman, Patricia ^a   Hiriart, Marcia ^b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Beta cell function; Diabetes; Insulin; Sodium arsenite

Indexed keywords

ARSENIC; ARSENITE SODIUM; GLUCOSE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; GENETIC TRANSCRIPTION; INSULIN RELEASE; INSULIN SYNTHESIS; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ARSENITES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN; INSULIN-SECRETING CELLS; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SODIUM COMPOUNDS; WATER POLLUTANTS, CHEMICAL;

EID: 33745011624     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.11.015     Document Type: Article

References (29)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 Suppl. 1 (2005) S37-S42
2. Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., Maslen G.L., Williams T.D., Lewis H., Schafer A.J., Chatterjee V.K., and O'Rahilly S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999) 880-883
3. Bazuine M., Ouwens D.M., Gomes de Mesquita D.S., and Maassen J.A. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. Eur. J. Biochem. 270 (2003) 3891-3903
4. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
5. Carter D.E., Aposhian H.V., and Gandolfi A.J. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol. Appl. Pharmacol. 193 (2003) 309-334
6. Cebrian M.E., Albores A., García-Vargas G., Del Razo L.M., Ostrosky-Wegman, and P. Chronic arsenic poisoning in humans: the case of Mexico. In: Nriagu J.O. (Ed). Arsenic in the Environment, Part II: Human Health and Ecosystem Effects (1994), John Wiley and Sons, Inc., New York 93-107
7. Cui X., Li S., Shraim A., Kobayashi Y., Hayakawa T., Kanno S., Yamamoto M., and Hirano S. Subchronic exposure to arsenic through drinking water alters expression of cancer-related genes in rat liver. Toxicol. Pathol. 32 (2004) 64-72
8. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., and Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49 (1999) 5-14
9. Hartmann A., and Speit G. Effect of arsenic and cadmium on the persistence of mutagen-induced DNA lesions in human cells. Environ. Mol. Mutagen. 27 (1996) 98-104
10. International Agency for Research on Cancer. Overall evaluations of carcinogenecity: an update of IARC Monographs. IARC Monogr. Eval. Carcinog. Risks Hum. 1-42 (1987) 173-259
11. Kaltreider R.C., Davis A.M., Lariviere J.P., and Hamilton J.W. Arsenic alters the function of the glucocorticoid receptor as a transcription factor. Environ. Health Perspect. 109 (2001) 245-251
12. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., and Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 139 (1994) 484-492
13. Maechler P., and Wollheim C.B. Mitochondrial function in normal and diabetic beta-cells. Nature 414 (2001) 807-812
14. Navarro-Tableros V., Sanchez-Soto M.C., Garcia S., and Hiriart M. Autocrine regulation of single pancreatic beta-cell survival. Diabetes 53 (2004) 2018-2023
15. Rahman M., and Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup. Environ. Med. 52 (1995) 773-774
16. Rahman M., Wingren G., and Axelson O. Diabetes mellitus among Swedish art glass workers-an effect of arsenic exposure?. Scand. J. Work Environ. Health 22 (1996) 146-149
17. Rahman M., Tondel M., Ahmad S.A., and Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 148 (1998) 198-203
18. Rea M.A., Gregg J.P., Qin Q., Phillips M.A., and Rice R.H. Global alteration of gene expression in human keratinocytes by inorganic arsenic. Carcinogenesis 24 (2003) 747-756
19. Rosenbaum T., Sanchez-Soto M.C., and Hiriart M. Nerve growth factor increases insulin secretion and barium current in pancreatic beta-cells. Diabetes 50 (2001) 1755-1762
20. Tseng C.H. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol. 197 (2004) 67-83
21. Tseng C.H., Chong C.K., Heng L.T., Tseng C.P., and Tai T.Y. The incidence of type 2 diabetes mellitus in Taiwan. Diabetes Res. Clin. Pract. 50 Suppl 2 (2000) S61-S64
22. Tseng C.H., Tai T.Y., Chong C.K., Tseng C.P., Lai M.S., Lin B.J., Chiou H.Y., Hsueh Y.M., Hsu K.H., and Chen C.J. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ. Health Perspect. 108 (2000) 847-851
23. Vahter M.E. Arsenic. In: Clarkson T.W., Friberg L., Nordberg G.F., and Sager P.R. (Eds). Biological Monitoring of Toxic Metals (1998), Plenum Press, New York 303-321
24. Vidaltamayo R., Sánchez-Soto M.C., Rosenbaum T., Martínez-Merlos T., and Hiriart M. Neuron-like phenotypic changes in pancreatic beta-cells induced by NGF, FGF and dbcAMP. Endocrine 4 (1996) 19-26
25. Walton F.S., Harmon A.W., Paul D.S., Drobna Z., Patel Y.M., and Styblo M. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 198 (2004) 424-433
26. Wauson E.M., Langan A.S., and Vorce R.L. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicol. Sci. 65 (2002) 211-219
27. Wu M.M., Chiou H.Y., Ho I.C., Chen C.J., and Lee T.C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ. Health Perspect. 111 (2003) 1429-1438
28. Yoshida T., Yamauchi H., and Fan Sun G. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol. Appl. Pharmacol. 198 (2004) 243-252
29. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787